MPT: NOAC Combo Tx Can Eliminate Need for Aspirin After PCI

ACC Conference Reporter

ESC 2017 | BARCELONA — Atrial fibrillation (Afib) patients on triple therapy after percutaneous coronary intervention (PCI) can safely avoid aspirin by switching to dual antithrombotic therapy with dabigatran (Pradaxa) and a P2Y12 inhibitor, researchers of the RE-DUAL trial found. Read More >>>

Keywords: ESC2017, ESC Congress

< Back to Listings